Predicting growth in response to growth hormone treatment

Growth Hormone and IGF Research

Volumn 19, Issue 1, 2009, Pages 1-11

  Ranke, Michael B ^a   Lindberg, Anders ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b PFIZER INC   (United States)

Author keywords

Growth prediction models; Pfizer international growth database

Indexed keywords

DEOXYPYRIDINOLINE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

CHILD GROWTH; DOSE RESPONSE; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SHORT STATURE; SMALL FOR DATE INFANT; TREATMENT OUTCOME; TURNER SYNDROME;

CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LONGITUDINAL STUDIES; MALE; MODELS, BIOLOGICAL; TREATMENT OUTCOME;

EID: 58649107149     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.08.001     Document Type: Review

References (49)

1. Bakker B., Frane J., Anhalt H., Lippe B., and Rosenfeld R.G. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J. Clin. Endocrinol. Metab. 93 (2008) 352-357
2. Ranke M.B., Lindberg A., Martin D.D., et al. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J. Clin. Endocrinol. Metab. 88 (2003) 4748-4753
3. Ranke M., Lindberg A., Chatelain P., et al. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. J. Clin. Endocrinol. Metab. 84 (1999) 1174-1183
4. Preece M., Tanner J., Whitehouse R., and Cameron N. Dose dependence of growth response to human growth hormone in growth hormone deficiency. J. Clin. Endocrinol. Metab. 42 (1976) 477-483
5. Frasier S.D., Costin G., Lippe B.M., Aceto Jr. T., and Bunger P.F. A dose-response curve for human growth hormone. J. Clin. Endocrinol. Metab. 53 (1981) 1213-1217
6. Albertsson-Wikland K. The effect of human growth hormone injection frequency on linear growth rate. Acta Paediatr. Scand. 337 Suppl. (1987) 110-116
7. Wit J.M., van't Hof M.A., and Van den Brande J.L. The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children. Eur. J. Pediatr. 147 (1988) 588-592
8. Sherman B., Frane J., Johanson A., and Kaplan S. Predictors of response in treatment with methionyl human growth hormone. In: Underwood L. (Ed). Human Growth Hormone: Progress and Challenges (1988), Marcel Dekker, New York 131-142
9. Ranke M.B., and Guilbaud O. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi pharmacia international growth study. Acta Paediatr. Scand. 379 Suppl. (1991) 109-115 (discussion 116)
10. Blethen S., Compton P., Lippe B., Rosenfeld R., August G., and Johanson A. Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J. Clin. Endocrinol. Metab. 76 (1993) 574-579
11. Ranke M., Lindberg A., and Guilbaud O. Prediction of growth in response to treatment with growth hormone. In: Ranke M.B., and Gunnarsson R. (Eds). Progress in Growth Hormone - 5 years of KIGS (1994), J & J Verlag 97-111
12. Albertsson-Wikland K., Kriström B., Rosberg S., Svensson B., and Nierop A. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr. Res. 48 (2000) 475-484
13. Ranke M., Guilbaud O., Lindberg A., and Cole T. Prediction of growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi pharmacia international growth study. Acta Paediatr. 391 Suppl. (1993) 82-88
14. Ranke M., Lindberg A., Chatelain P., et al. Development of the KIGS model for predicting growth response to growth hormone replacement therapy in children with idiopathic growth hormone deficiency from start of treatment until final height. In: Ranke M.B., and Wilton P. (Eds). Growth hormone therapy in KIGS - 10 years' experience (1999), Johann Ambrosius Barth Verlag 371-384
15. Cook R.D., and Weisberg S. Residuals and Influence in Regression (1982), Chapman and Hall, New York
16. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15 (1996) 361-387
17. Weisberg S. Applied Linear Regression. second ed. (1985), Wiley and Sons, Chichester
18. Ranke M.B., Lindberg A., Albertsson-Wikland K., Wilton P., Price D.A., and Reiter E.O. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH deficiency: analysis of data from KIGS. J. Clin. Endocrinol. Metab. 90 (2005) 1966-1971
19. Ranke M., Lindberg A., Chatelain P., et al. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J. Clin. Endocrinol. Metab. 85 (2000) 4212-4218
20. Ranke M.B., Lindberg A., Cowell C.T., et al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J. Clin. Endocrinol. Metab. 88 (2003) 125-131
21. Ranke M., and Guilbaud O. Growth hormone levels in response to stimulation tests and responsiveness to growth hormone in children with growth hormone deficiency and idiopathic short stature. Kabi Pharmacia Int. Growth Stud. 8 1 (1992) 34-41
22. Spagnoli A., Spadoni G.L., Cianfarani S., Pasquino A.M., Troiani S., and Boscherini B. Prediction of the outcome of growth hormone therapy in children with idiopathic short stature. A multivariate discriminant analysis. J. Pediatr. 126 (1995) 905-909
23. Südfeld H., Kiese K., Heinecke A., and Brämswig J. Prediction of growth response in prepubertal children treated with growth hormone for idiopathic growth hormone deficiency. Acta Paediatr. Scand. 89 (2000) 34-37
24. Schönau E., Westermann F., Rauch F., et al. A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur. J. Endocrinol. 144 (2001) 13-20
25. Gibney J., and Johannsson G. Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal. Horm. Res. 62 Suppl 1 (2004) 66-72
26. Lee K.W., and Cohen P. Individualized growth hormone therapy in children: advances beyond weight-based dosing. J. Pediatr. Endocrinol. Metab. 16 Suppl. 3 (2003) 625-630
27. Dos Santos C., Essioux L., Teinturier C., Tauber M., Goffin V., and Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36 (2004) 720-724
28. Binder G., Baur F., Schweizer R., and Ranke M.B. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J. Clin. Endocrinol. Metab. 91 (2006) 659-664
29. Pilotta A., Mella P., Filisetti M., et al. Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J. Clin. Endocrinol. Metab. 91 (2006) 1178-1180
30. Jorge A.A., Marchisotti F.G., Montenegro L.R., Carvalho L.R., Mendonca B.B., and Arnhold I.J. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J. Clin. Endocrinol. Metab. 91 (2006) 1076-1080
31. Schreiner F., Stutte S., Bartmann P., Gohlke B., and Woelfle J. Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams. J. Clin. Endocrinol. Metab. 92 (2007) 4489-4493
32. Dahlgren J., Kristrom B., Niklasson A., Nierop A.F., Rosberg S., and Albertsson-Wikland K. Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age. BMC Med. Inf. Decis. Mak. 7 (2007) 40
33. Kriström B., Jansson C., Rosberg S., and Albertsson-Wikland K. On behalf of the Swedish study group for growth hormone treatment, growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. J. Clin. Endocrinol. Metab. 82 (1997) 2889-2898
34. Kriström B., Karlberg J., and Albertsson-Wikland K. Prediction of the growth response of short prepubertal children treated with growth hormone. Acta Paediatr. 84 (1995) 51-57
35. de Ridder M.A., Stijnen T., and Hokken-Koelega A.C. Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. J. Clin. Endocrinol. Metab. 92 (2007) 925-931
36. Land C., Blum W.F., Shavrikova E., Kloeckner K., Stabrey A., and Schoenau E. Predicting the growth response to growth hormone (GH) treatment in prepubertal and pubertal children with isolated GH deficiency-model validation in an observational setting (GeNeSIS). J. Pediatr. Endocrinol. Metab. 20 (2007) 685-693
37. de Ridder M.A., Stijnen T., and Hokken-Koelega A.C. Prediction model for adult height of SGA children at start of growth hormone treatment. J. Clin. Endocrinol. Metab. 93 (2008) 477-483
38. Ranke M.B., and Dowie J. KIGS and KIMS as tools for evidence-based medicine. Horm. Res. 51 Suppl. 1 (1999) 83-86
39. Wallström A., and Trulsson L. The Kabi International Growth Study: rationale, organisation and development. In: Gunnarsson R., and Ranke M.B. (Eds). Progress in Growth Hormone Therapy - 5 Years of KIGS (1994), J & J Verlag 1-9
40. Ranke M.B. The Kabi Pharmacia International Growth Study: aetiology classification list with comments. Acta Paediatr. Scand. Suppl 379 (1991) 87-92
41. Blethen S., Baptista J., Kuntze J., et al. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J. Clin. Endocrinol. Metab. 82 (1997) 418-420
42. Dowie J. What decision analysis can offer the clinical decision maker. Why outcome databases such as KIGS and KIMS are vital sources for decision analysis. Horm. Res. 51 Suppl. 1 (1999) 73-82
43. Rauch F., Georg M., Stabrey A., et al. Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin. Chem. 48 (2002) 315-322
44. Tobiume H., Kanzaki S., Hida S., et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J. Clin. Endocrinol. Metab. 82 (1997) 2056-2061
45. Hoos M.B., Westerterp K.R., and Gerver W.J. Short-term effects of growth hormone on body composition as a predictor of growth. J. Clin. Endocrinol. Metab. 88 (2003) 2569-2572
46. Vosahlo J., Zidek T., Lebl J., Riedl S., and Frisch H. Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency. Horm. Res. 61 (2004) 143-147
47. de Ridder M.A., Stijnen T., and Hokken-Koelega A.C. Validation and calibration of the Kabi Pharmacia International Growth Study prediction model for children with idiopathic growth hormone deficiency. J. Clin. Endocrinol. Metab. 88 (2003) 1223-1227
48. de Ridder M.A., Stijnen T., Drop S.L., Blum W.F., and Hokken-Koelega A.C. Validation of a calibrated prediction model for response to growth hormone treatment in an independent cohort. Horm. Res. 66 (2006) 13-16
49. de Ridder M.A., Stijnen T., and Hokken-Koelega A.C. Prediction model for adult height of SGA children at start of growth hormone treatment. J. Clin. Endocrinol. Metab. 12 (2007) 12